ArticleObesity surgery2020
Outcomes of Bariatric Surgery in Chronic Liver Disease: a National Inpatient Sample Analysis.
Article in Obesity surgery, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 12 citations in OpenAlex.
- Is Bariatric Surgery Safe to Perform in Patients with Chronic Liver Disease? A National Cross-Sectional Study.Obesity surgery · 2025Article
- Assessment of Metabolic and Bariatric Surgery Safety in Patients with Advanced Liver Fibrosis.Obesity surgery · 2024Article
- Guidance document: risk assessment of patients with cirrhosis prior to elective non-hepatic surgery.Frontline gastroenterology · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionObesity is a challenging condition to treat in patients with chronic liver disease (CLD). The safety and efficacy of bariatric surgery (BS) in patients with CLD is not well established. The aim of this study is to evaluate outcomes of BS in patients with CLD.
methodsData from the National Inpatient Sample for 2012-2015, accounting for over 7 million discharges, were analyzed. All patients undergoing BS were identified using ICD-9/CPT codes. Patients were then stratified based on the presence of CLD using ICD-9 codes. Primary outcomes included inpatient mortality, length of stay (LOS), and total hospital charges (THC). Secondary outcomes, including infection, bleeding, improper wound healing, and surgical revision, were identified using ICD-9 codes.
resultsA total of 302,306 patients underwent BS, of which 20,095 (6.6%) were diagnosed with CLD. CLD patients had greater inpatient mortality, with adjusted odds ratio of 1.47 (95% CI 1.24-1.73). CLD patients also had greater THC but shorter LOS. CLD patients had significantly less surgical revision, improper wound healing, and postoperative infection. There was no difference in bleeding complications between groups.
conclusionInpatient mortality following BS in CLD patients is low; however, there was an increased risk compared with the non-CLD population. Postoperative complications were no different or even less frequent in CLD patients compared with the general population. BS should not be discounted as a treatment option for obesity in patients with CLD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.